Today In "It Will Take Twelve Decades to Flatten the Curve" News

Canada isn't the only country to botch a flu and use it control every aspect of people's lives:

Ontario is pausing the lifting of capacity limits for remaining indoor “higher-risk settings” as a preventative measure due to an increase in COVID-19 cases, the province announced on Nov. 10.

The province says that while it has one of the lowest rates of active cases across the country, and that hospital and intensive care capacity remains stable, the effective reproduction number and percent positivity have “have increased slightly over the past week.”

The province of Ontario has 2,300 intensive care unit beds (ICU). As of this writing, only 133 beds are occupied by patients with COVID-19.

As you can see, it's time to cancel Christmas.

 

The Grinch cannot believe what he is hearing.

How other countries are punishing those who would rather not have an experimental flu shot injected into them:

The country with one of the lowest inoculation rates in western Europe may soon announce a nationwide lockdown for the unvaccinated or those that haven’t recently recovered from the illness, according to Chancellor Alexander Schallenberg. The hardest-hit province of Upper Austria, located between the German and Czech borders, plans to implement the measure starting Monday. Under the new rules, those who haven’t had shots would only be allowed to leave home for work and to buy essential goods. ...

Many public agencies required that employees get vaccinated or face dismissal. Fifty unvaccinated employees of the police and border guard agency are suing their agency over this policy and on Thursday a court granted them temporary relief pending further review of the policy.

Phenomenal planning there, Chrystia.

I can see why Justin out you in charge:

Another one-month extension of pandemic benefits will cost more than a quarter billion. “We have to finish the fight against Covid,” said Finance Minister Chrystia Freeland: “We have done, I would say, a pretty good job.”

 

Get your fourth jab, you flat-earther!:

The @nytimes published "What We Know So Far About
Waning Vaccine Effectiveness" today
It is misleading and missing key reports from New York State, Veterans Affairs, Puerto Rico, Israel, Qatar, the UK, and several othershttps://t.co/ST758q2d17

— Eric Topol (@EricTopol) November 11, 2021

 

These "vaccines":

Health Canada says a decision on whether to authorize a COVID-19 vaccine for children will come “in the next one to two weeks,” leaving open the possibility that some kids could be at least partially protected by Christmas.

Canada’s chief medical adviser Dr. Supriya Sharma said in a conference call with reporters Friday that the regulator is “actively continuing” its review of the Pfizer-BioNtech jab for children aged five to 11, which was authorized for use in the United States last week.

**

There's a lot of money in those patents:

The National Institutes of Health (NIH) and Moderna are engaged in a dispute over which scientists developed Moderna’s COVID-19 vaccine, with the conflict possibly heading to court.

Moderna and government scientists collaborated on the development of the shot and the government asked the company to include a trio of scientists on its patent application. But company officials said in a patent filing in July for a key sequence that’s part of the vaccine that they “have reached a good-faith determination” that the scientists did not invent it.

The filing “took NIH officials by surprise,” a government official familiar with the situation told The Epoch Times in an email on condition of anonymity.

The agency disagrees and a review of the matter determined Drs. Kizzmekia Corbett, Barney Graham, and John Mascola, who all worked with Moderna while at the NIH, are co-inventors of the component and should be named as such.

“Omitting NIH inventors from the principal patent application deprives NIH of a co-ownership interest in that application and the patent that will eventually issue from it,” the official said.

 

This Moderna: 

Sweden's Public Health Agency on Wednesday recommended a temporary halt to the use of the Moderna COVID-19 vaccine among young adults, citing concerns over rare side effects to the heart. It said the pause should initially be in force until December 1, explaining that it had received evidence of an increased risk of side effects such as inflammation of the heart muscle (myocarditis) and inflammation of the pericardium (pericarditis).

**

Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.

According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases of capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.

“At this stage, it is not yet clear whether there is a causal association between vaccination and the reports of capillary leak syndrome,” the EMA wrote on Thursday, adding that “these reports point to a safety signal … information on new, or changes in, adverse events that may potentially be associated with a medicine or vaccine and that warrant further investigation.”

The review also will address the risk of capillary leak syndrome in groups who have a medical history of the disorder.

As a result, EMA researchers will “evaluate all the available data to decide if a causal relationship is considered likely or not,” the bulletin reads.

**

Moderna has been paused for youth in some countries over heart inflammation issues. At the same time, Moderna has begun testing its COVID-19 vaccine on young children, the company announced Tuesday.

The study, called KidCOVE, is testing Moderna’s vaccine candidate in children ages 6 months to less than 12 years old.

“It is humbling to know that 53 million doses have been administered to people in the U.S.,” Stéphane Bancel, chief executive officer of Moderna, said in a statement. “We are encouraged by the primary analysis of the Phase 3 COVE study of mRNA-1273 in adults ages 18 and above and this pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population.”

 

I would say frightening.

 

 

An institution too big to fail:

“There is a clear imbalance between the high cost of Canada’s health-care system and the value Canadians receive in terms of availability of resources and timely access to care,” said report co-author Bacchus Barua, director of health policy studies at the Fraser Institute, in a Nov. 4 news release.

The authors analyzed cost by using two indicators to measure the level of health-care expenditures in those 28 countries. Performance of those countries’ health systems was examined using 40 indicators representing the four broad categories of availability of resources, use of resources, access to resources, and clinical performance and quality.

According to the OECD’s latest data from 2019, Canada’s spending on health care as a share of its GDP (11.3 percent) is the second-highest among the 28 countries (after making adjustments for the percentage of the population over age 65), coming behind only Switzerland (11.4 percent).

Despite its high expenditures, Canada is seeing “generally worse” availability and access to medical resources compared to the other countries, the authors found.

** 

Their credentials weren't accepted because they weren't Canadian and I doubt that anyone would consider hiring them were it not for laying off medical professionals for refusing the flu shots:

Over 21 months into the COVID-19 pandemic, Canada’s public health systems are stretched thin while thousands of foreign-trained doctors living in Canada remain sidelined due to credentialing and licensing policies.

**

Canadian physicians and scientists say they’re concerned over a lack of access to important COVID-19 treatments that can prevent some infections from becoming severe or deadly.

Health experts say the issue warrants immediate attention as cases in many parts of the country start to rise again.

Interest has grown in recent weeks over two new antiviral pills that may reduce the number of people who become severely ill with COVID-19.

While those two drugs aren’t yet approved here, Health Canada has authorized a handful of treatments called monoclonal antibodies that can reduce severe illness when given to people within a few days of symptom onset.

However, treatment with monoclonal antibodies, which must be administered intravenously, is not widely available to those who would benefit most in many parts of Canada, according to Andrew Morris, an infectious-disease physician at Toronto’s Mount Sinai Hospital and University Health Network.

“It’s almost random how people can get access to it,” said Dr. Morris, who is also a member of Ontario’s COVID-19 Science Advisory Table. “Most doctors and other health care providers have no idea how to access it.”

 

Two years to figure that out yet no one has.

Strange.

**

The survey shows the pandemic has dramatically changed perceptions, preferences and ultimately the financial behaviour of Canadians when it comes to long-term care.

A full 72 per cent of our respondents said they were less inclined to enter a nursing home, and 70 per cent of them said the pandemic caused them serious concerns about exposure to health risks in long-term care facilities.

At the same time, about 25 per cent said they planned to save more for old age because of COVID-19 and their desire to avoid entering nursing homes in favour of home care.